13 /100
LOW RISK
Score updated May 29, 2026

FATE — Fate Therapeutics, Inc. Dilution Risk Tracker

Track FATE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FATE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
19%
🔄 Reverse Split 30%
• 50-day avg $1.57 approaching $1 threshold
🔁 Convertible Conversion 15%
• Convertible debt present: 6.5% potential dilution
🔔 Track FATE — Get forecast alerts →

💹 Market Data

Market Cap$306.55M
Shares Outstanding116.56M
Float101.89M
Cash$174.82M
Debt$76.78M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 11.3% shares (2025Q4 vs prior)
142 institutional holders · 72.64M shares
#1 Redmile Group, LLC 12.87M shares
#2 BlackRock, Inc. 10.18M shares
#3 VANGUARD GROUP INC 8.97M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest10.26M
Days to Cover9.3
% of Float10.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2017
xbrl XBRL CONVERTIBLE Dec 31, 2013
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track FATE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FATE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for FATE
📊 FATE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FATE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.